National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$69.95
add to cart

Rights & Permissions

topleft topright

Dietary Reference Intakes for Calcium and Vitamin D (2011)
Food and Nutrition Board (FNB)

Citation Manager

. "4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D." Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.

Please select a format:

BibTeX EndNote RefMan


Page
208
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


DRI Dietary Reference Intakes Calcium Vitamin D

Reference;

Country;

Jadad Score for RCTsb

Population Description

Intervention/Duration

Bone Health Outcomes

Results

Before-and-after studies

Rajakumar et al., 2005

Healthy 6–10 y olds

Tanner stage I/II (81% I)

Skin type III/IV (81% IV); mean age 8.9 (1.2) y (range 6–10 y)

400 IU vit D/d (isoform not specified)

iPTH (Immulite iPTH chemiluminescent assay)

Serum 25OHD, mean (SD) (nmol/L)

Baseline: 60.0 (26.3)

49% < 50

71% < 75

United States

 

 

1 mo

 

 

 

 

 

Group 1 = 25OHD < 50 nmol/L at baseline: 38.5 (8.0)

Group 2 = 25OHD > 50 nmol/L at baseline: 80.3 (20.5)

 

 

 

1 mo (total group): 68.8 (18.8)

Group 1: 57.5 (16.0)

Group 2: 79.5 (14.5)

Increase in serum 25OHD was observed only in group 1

7/39 (18%) of group 1 continued to have a level < 50 nmol/L after 1 mo of supplementation

 

Vit D dietary intake: mean (SD) 277 (146) IU/d 16/41 (39%) dietary intake < 200 IU/d

 

 

 

 

 

Negative correlation of 25OHD with body weight (r = −0.378, p = 0.015) at baseline

 

n = 42

 

 

 

34% female

 

 

No significant differences at baseline or 1 mo in markers of bone turnover, 1,25(OH)2D or PTH between groups with 25OHD < 50 nmol/L or > 50 nmol/L at baseline

 

African American

 

 

NOTE: BMAD = bone mineral apparent density; BMC = bone mineral content; BMD = bone mineral density; CG = control group; DXA = dual-energy X-ray absorptiometry; FN = femoral neck; IG = intervention group; iPTH = intact parathyroid hormone; IU = International Units; LS = lumbar spine; LSES = lower socioeconomic status; mo = month(s); NA = not applicable; PTH = parathyroid hormone; RCT = randomized controlled trial; SD = standard deviation; SPA = single-photon absorptiometry; UK = United Kingdom; USES = upper socioeconomic status; vit = vitamin; wk = week(s); y = year(s).

aThis table has been truncated for the purposes of this chapter, but it can be found in its entirety in Appendix C.

bJadad score is based on a scale of 1 to 5. See Box 4-1 for details on the scoring system.

SOURCE: Modified from Cranney et al. (2007).

Page
208
Front Matter (R1-R16)
Summary (1-14)
1 Introduction (15-34)
2 Overview of Calcium (35-74)
3 Overview of Vitamin D (75-124)
4 Review of Potential Indicators of Adequacy and Selection of Indicators: Calcium and Vitamin D (125-344)
5 Dietary Reference Intakes for Adequacy: Calcium and Vitamin D (345-402)
6 Tolerable Upper Intake Levels: Calcium and Vitamin D (403-456)
7 Dietary Intake Assessment (457-478)
8 Implications and Special Concerns (479-512)
9 Information Gaps and Research Needs (513-522)
Appendix A: Acronyms, Abbreviations, and Glossary (523-536)
Appendix B: Issues and Interests Identified by Study Sponsors (537-538)
Appendix C: Methods and Results from the AHRQ-Ottawa Evidence-Based Report on Effectiveness and Safety of Vitamin D in Relation to Bone Health (539-724)
Appendix D: Methods and Results from the AHRQ-Tufts Evidence-Based Report on Vitamin D and Calcium (725-1012)
Appendix E: Literature Search Strategy (1013-1018)
Appendix F: Evidence Maps (1019-1024)
Appendix G: Cases Studies of Vitamin D Toxicity (1025-1034)
Appendix H: Estimated Intakes of Calcium and Vitamin D from National Surveys (1035-1044)
Appendix I: Proportion of the Population Above and Below 40 nmol/L Serum 25-Hydroxyvitamin D Concentrations and Cumulative Distribution of Serum 25-Hydroxyvitamin D Concentrations: United States and Canada (1045-1058)
Appendix J: Workshop Agenda and Open Session Agendas (1059-1064)
Appendix K: Biographical Sketches of Committee Members (1065-1074)
Index (1075-1102)
Summary Tables: Dietary Reference Intakes (1103-1116)